{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:44:27Z","timestamp":1751625867555,"version":"3.37.3"},"reference-count":9,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lithium is a mood-stabilizing medication approved by the FDA for the treatment of acute manic or mixed episodes of bipolar disorder as well as maintenance treatment. Lithium citrate is an oral solution, and the carbonate salt is available as oral capsules or extended-release tablets. A patient with a psychiatric history of PTSD and schizoaffective disorder\u2013bipolar type, maintained on lithium and olanzapine prior to admission, was admitted to an inpatient psychiatric unit due to destabilization, paranoia, and mania. He was started on lithium citrate, administered with apple juice, while admitted due to nonadherence. An initial serum lithium concentration was found to be undetectable. Lithium was then administered with an alternative non\u2013apple juice liquid, at which point serum lithium concentration became detectable and patient clinically improved. Lithium concentrations may be impacted by a number of causes, such as underlying medical conditions, drug interactions, and diet. As the majority of these factors remained stable during the patient's admission and the serum lithium concentration became detectable after switching from apple juice to an alternative non\u2013apple juice liquid, it led to the identification of a possible incompatibility.<\/jats:p>","DOI":"10.9740\/mhc.2021.01.027","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:48:58Z","timestamp":1610585338000},"page":"27-30","source":"Crossref","is-referenced-by-count":3,"title":["Undetectable serum lithium concentrations after coadministration of liquid lithium citrate and apple juice: A case report"],"prefix":"10.9740","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7693-8140","authenticated-orcid":true,"given":"Sundus","family":"Awan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-8143","authenticated-orcid":true,"given":"Audrey","family":"Abelleira","sequence":"additional","affiliation":[{"name":"PGY-2 Psychiatric Pharmacy Resident, Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8186-9220","authenticated-orcid":true,"given":"Loveleen","family":"Khehra","sequence":"additional","affiliation":[{"name":"PGY-2 Psychiatry Medical Resident, Rosalind Franklin University, North Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-2631","authenticated-orcid":true,"given":"Robin","family":"Hieber","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Mental Health, Veterans Integrated Service Network 23 Clinical Resource Hub, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"2021012100102985000_i2168-9709-11-1-27-b01","unstructured":"Lithium oral solution [package insert]. Eatontown (NJ): West-Ward Pharmaceuticals Corp; 2020."},{"key":"2021012100102985000_i2168-9709-11-1-27-b02","doi-asserted-by":"crossref","unstructured":"Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34(4):280-5. DOI: 10.1002\/j.1552-4604.1994.tb01994.x. PubMed PMID: 8006194.","DOI":"10.1002\/j.1552-4604.1994.tb01994.x"},{"key":"2021012100102985000_i2168-9709-11-1-27-b03","doi-asserted-by":"crossref","unstructured":"Finley PR. Drug interactions with lithium: an update. Clin Pharmacokinet. 2016;55(8):925-41. DOI: 10.1007\/s40262-016-0370-y. PubMed PMID: 26936045.","DOI":"10.1007\/s40262-016-0370-y"},{"key":"2021012100102985000_i2168-9709-11-1-27-b04","unstructured":"Sanacora G. New understanding of mechanisms of action of bipolar medications. J Clin Psychiatry. 2008;69Suppl 5:22-7. PubMed PMID: 19265637."},{"key":"2021012100102985000_i2168-9709-11-1-27-b05","doi-asserted-by":"crossref","unstructured":"Ware K, Tillery E, Linder L. General pharmacokinetic\/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder. Ment Health Clin [Internet]. 2016;6(1):54-61. DOI: 10.9740\/mhc.2016.01.054. PubMed PMID: 29955448; PubMed Central PMCID: PMC6009247.","DOI":"10.9740\/mhc.2016.01.054"},{"key":"2021012100102985000_i2168-9709-11-1-27-b06","doi-asserted-by":"crossref","unstructured":"Sanborn K, Jefferson J. Everyman's guide to the fluctuating lithium level: obvious and obscure reasons why serum lithium levels change. Ann Clin Psychiatry. 1991;3(3):251-8. DOI: 10.3109\/10401239109147999.","DOI":"10.3109\/10401239109147999"},{"key":"2021012100102985000_i2168-9709-11-1-27-b07","doi-asserted-by":"crossref","unstructured":"Shirasaka Y, Shichiri M, Murata Y, Mori T, Nakanishi T, Tamai I. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption. Drug Metab Dispos. 2012;41(3):615-21. DOI: 10.1124\/dmd.112.049635. PubMed PMID: 23264447.","DOI":"10.1124\/dmd.112.049635"},{"key":"2021012100102985000_i2168-9709-11-1-27-b08","doi-asserted-by":"crossref","unstructured":"Geller JL, Gaulin BD, Barreira PJ. A practitioner's guide to use of psychotropic medication in liquid form. PS. 1992;43(10):969-71. DOI: 10.1176\/ps.43.10.969. PubMed PMID: 1356908.","DOI":"10.1176\/ps.43.10.969"},{"key":"2021012100102985000_i2168-9709-11-1-27-b09","doi-asserted-by":"crossref","unstructured":"Kerr LE. Oral liquid neuroleptics. Psychosocial Nurs Ment Health Serv. 1986;24(3):33-5.","DOI":"10.3928\/0279-3695-19860301-09"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/11\/1\/27\/2713738\/i2168-9709-11-1-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/11\/1\/27\/2713738\/i2168-9709-11-1-27.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:19:09Z","timestamp":1731687549000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/11\/1\/article-p27.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,8]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2021.01.027","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}